|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/7105 | |
| A61P 35/00 | |||
| C12N 15/11 |
| (11) | Patento numeris | 2217248 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 08844596.0 |
| Europos patento paraiškos padavimo data | 2008-10-29 | |
| (97) | Europos patento paraiškos paskelbimo data | 2010-08-18 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2016-11-30 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2008/081645 |
| Data | 2008-10-29 |
| (87) | Numeris | WO 2009/058907 |
| Data | 2009-05-07 |
| (30) | Numeris | Data | Šalis |
| 983231 P | 2007-10-29 | US |
| (72) |
BENNETT, C., Frank, US
CHAJUT, Ayelet, IL
ESAU, Christine, US
MARCUSSON, Eric, G., US
YERUSHALMI, Noga, IL
|
| (73) |
Regulus Therapeutics Inc.,
10614 Science Center Drive, San Diego, CA 92121,
US
Rosetta Genomics Ltd., 10 Plaut Street, 76706 Rehovot, IL |
| (54) | TARGETING MICRORNAS FOR THE TREATMENT OF LIVER CANCER |
| TARGETING MICRORNAS FOR THE TREATMENT OF LIVER CANCER |